Bone Loss Prevention with Zoledronic Acid or Denosumab in Critically Ill Women – A Randomised Controlled Trial (Bone Zone)

  • Orford, Neil (Primary Chief Investigator (PCI))
  • Center, Jacqueline R (Chief Investigator (CI))
  • Nair, Priya V (Chief Investigator (CI))
  • Cooper, Jamie (Chief Investigator (CI))
  • Hodgson, Carol (Chief Investigator (CI))
  • Kotowicz, Mark Anthony (Chief Investigator (CI))
  • Pasco, Julie (Chief Investigator (CI))
  • Bailey, Michael (Chief Investigator (CI))
  • Venkatesh, Bala (Chief Investigator (CI))
  • Myburgh, John (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date1/06/20 → 31/05/26

Keywords

  • randomised controlled trial (RCT)
  • critical care
  • bone density
  • fracture risk
  • women's health